BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16400638)

  • 1. Value of postoperative stereotactic radiosurgery and conventional radiotherapy for incompletely resected typical neurocytomas.
    Rades D; Schild SE
    Cancer; 2006 Mar; 106(5):1140-3. PubMed ID: 16400638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the best available treatment for neurocytomas in children.
    Rades D; Schild SE; Fehlauer F
    Cancer; 2004 Dec; 101(11):2629-32. PubMed ID: 15494975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is 50 Gy sufficient to achieve long-term local control after incomplete resection of typical neurocytomas?
    Rades D; Schild SE
    Strahlenther Onkol; 2006 Jul; 182(7):415-8. PubMed ID: 16826361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment for central neurocytoma: a meta-analysis based on the data of 358 patients].
    Rades D; Fehlauer F; Schild S; Lamszus K; Alberti W
    Strahlenther Onkol; 2003 Apr; 179(4):213-8. PubMed ID: 12707710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of atypical neurocytomas.
    Rades D; Fehlauer F; Schild SE
    Cancer; 2004 Feb; 100(4):814-7. PubMed ID: 14770439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-effect relationship for radiotherapy after incomplete resection of atypical neurocytomas.
    Rades D; Fehlauer F; Ikezaki K; Schild SE
    Radiother Oncol; 2005 Jan; 74(1):67-9. PubMed ID: 15683672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Well-differentiated neurocytoma: what is the best available treatment?
    Rades D; Fehlauer F; Lamszus K; Schild SE; Hagel C; Westphal M; Alberti W
    Neuro Oncol; 2005 Jan; 7(1):77-83. PubMed ID: 15701284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of meningeal melanocytomas.
    Rades D; Schild SE; Tatagiba M; Molina HA; Alberti W
    Cancer; 2004 Jun; 100(11):2442-7. PubMed ID: 15160350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma knife radiosurgery for central neurocytoma: primary and secondary treatment.
    Kim CY; Paek SH; Jeong SS; Chung HT; Han JH; Park CK; Jung HW; Kim DG
    Cancer; 2007 Nov; 110(10):2276-84. PubMed ID: 17926332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
    Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases.
    Rades D; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Nov; 110(10):2285-92. PubMed ID: 17922523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
    Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment recommendations for the various subgroups of neurocytomas.
    Rades D; Schild SE
    J Neurooncol; 2006 May; 77(3):305-9. PubMed ID: 16575540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of central neurocytoma: radiotherapy.
    Barani IJ; Raleigh DR; Larson D
    Neurosurg Clin N Am; 2015 Jan; 26(1):45-56. PubMed ID: 25432183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant stereotactic radiosurgery after resection of intracranial hemangiopericytomas.
    Kano H; Niranjan A; Kondziolka D; Flickinger JC; Lunsford LD
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1333-9. PubMed ID: 18723295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
    Samlowski WE; Majer M; Boucher KM; Shrieve AF; Dechet C; Jensen RL; Shrieve DC
    Cancer; 2008 Nov; 113(9):2539-48. PubMed ID: 18780316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cranial base chordoma--long term outcome and review of the literature.
    Yoneoka Y; Tsumanuma I; Fukuda M; Tamura T; Morii K; Tanaka R; Fujii Y
    Acta Neurochir (Wien); 2008 Aug; 150(8):773-8; discussion 778. PubMed ID: 18548191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical management of intraventricular central neurocytoma: 92 cases.
    Qian H; Lin S; Zhang M; Cao Y
    Acta Neurochir (Wien); 2012 Nov; 154(11):1951-60. PubMed ID: 22941394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of posterior third ventricular central neurocytoma with endoscopic biopsy, endoscopic third ventriculostomy and stereotactic radiosurgery.
    Javedan SP; Manwaring K; Smith KA
    Minim Invasive Neurosurg; 2003 Jun; 46(3):165-8. PubMed ID: 12872194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.